4.5 Article

Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure

Journal

JOURNAL OF HYPERTENSION
Volume 31, Issue 1, Pages 77-85

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/HJH.0b013e32835a8eb1

Keywords

applanation tonometry; central blood pressure; hypertension; oscillometric signals; pulse wave analysis; wave reflection

Funding

  1. NIHR Cambridge Biomedical Research Centre
  2. Cambridge University Hospitals
  3. Comprehensive Local Research Network
  4. British Heart Foundation
  5. British Heart Foundation [FS/12/8/29377] Funding Source: researchfish

Ask authors/readers for more resources

Objectives: The Vicorder is a new brachial cuff-based device that estimates central blood pressure (cBP) using a brachial-to-aortic transfer function. The aim of this study was to evaluate cBP estimated by the Vicorder. Methods: During cardiac angiography, cBP estimated by the Vicorder and the SphygmoCor was evaluated against simultaneous invasive cBP in 50 patients. The two devices were also compared noninvasively in a separate group of 90 healthy individuals. Results: Central SBP (cSBP) obtained with each device satisfied the American Association for the Advancement of Medical Instrumentation accuracy criteria when peripheral waveforms were calibrated to invasive mean arterial pressure (MAP)/DBP: estimated - invasive cSBP difference, -4.0 +/- 7.4mmHg, Vicorder, P < 0.001; -1.4 +/- 7.9 mmHg, SphygmoCor, P = 0.21. When oscillometric brachial SBP/DBP was used for peripheral waveform calibration, cSBP was underestimated by Vicorder (Delta - 6.4 +/- 7.4mmHg, P < 0.001 versus invasive) and more so by SphygmoCor (Delta - 11.9 +/- 7.2mmHg, P < 0.001 versus invasive). Conversely, cSBP was more closely estimated by SphygmoCor when waveforms were calibrated to brachial MAP/DBP (Delta - 2.8 +/- 9.4 mmHg, P = 0.04 versus invasive). In the noninvasive study, Vicorder cSBP correlated well with SphygmoCor cSBP when SphygmoCor waveforms were calibrated to brachial MAP/DBP (121 +/- 16 versus 121 +/- 17 mmHg, P = 0.2) but not when brachial SBP/DBP was used for calibration (115 +/- 19 mmHg, P < 0.001). Conclusion: The Vicorder and SphygmoCor devices provide reliable estimates of cSBP when calibrated to invasive pressure. When calibrated to brachial BP, both devices underestimated cSBP, although this was attenuated when SphygmoCor was calibrated to brachial MAP/DBP. Vicorder may be a simple alternative to tonometry-based methods for noninvasive assessment of cBP.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Geriatrics & Gerontology

Short physical performance battery as a practical tool to assess mortality risk in chronic obstructive pulmonary disease

Jilles M. Fermont, Divya Mohan, Marie Fisk, Charlotte E. Bolton, William Macnee, John R. Cockcroft, Carmel McEniery, Jonathan Fuld, Joseph Cheriyan, Ruth Tal-Singer, Hana Mullerova, Angela M. Wood, Ian B. Wilkinson, Michael Polkey

Summary: The study found that using the SPPB and its components as an alternative to the 6MWT in the BODE Index maintained a similar predictive ability for mortality in COPD patients.

AGE AND AGEING (2021)

Article Biophysics

Towards the non-invasive determination of arterial wall distensible properties: New approach using old formulae

Ye Li, Alessandro Giudici, Ian B. Wilkinson, Ashraf W. Khir

Summary: Arterial function and wall mechanical properties play crucial roles in circulation hemodynamics. A novel non-invasive method for determining vessel distensibility and elastic modulus was proposed and validated, showing comparable results to invasive techniques. This new approach holds potential for clinical applications.

JOURNAL OF BIOMECHANICS (2021)

Article Cardiac & Cardiovascular Systems

Oxidation of Protein Kinase A Regulatory Subunit PKARIα Protects Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Lysosomal-Triggered Calcium Release

Jillian N. Simon, Besarte Vrellaku, Stefania Monterisi, Sandy M. Chu, Nadiia Rawlings, Oliver Lomas, Gerard A. Marchal, Dominic Waithe, Fahima Syeda, Parag R. Gajendragadkar, Raja Jayaram, Rana Sayeed, Keith M. Channon, Larissa Fabritz, Pawel Swietach, Manuela Zaccolo, Philip Eaton, Barbara Casadei

Summary: The study revealed that PKARI alpha disulfide formation is significantly increased in response to I/R in both humans and mice, leading to enhanced AKAP binding and preferential localization to the lysosome. This redox-dependent regulation of lysosomal channels by PKARI alpha plays a critical role in protecting the heart from extensive injury and could serve as a novel target for cardioprotective therapeutics.

CIRCULATION (2021)

Editorial Material Rheumatology

Baricitinib set to join the Covid-19 therapeutic arsenal?

Tania Gudu, Carmel Stober, Andrew P. Cope, Joseph Cheriyan, James Galloway, Ian B. Wilkinson, Michalis Kostapanos, David Jayne, Frances Hall

RHEUMATOLOGY (2021)

Article Peripheral Vascular Disease

Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition-Induced Hypertension The HYPAZ Trial

Kaisa M. Maki-Petaja, Adam McGeoch, Lucy L. Yang, Annette Hubsch, Carmel M. McEniery, Paul A. R. Meyer, Fraz Mir, Parag Gajendragadkar, Nicola Ramenatte, Gayathri Anandappa, Sara Santos Franco, Simon J. Bond, Carola-Bibiane Schonlieb, Yoeri Boink, Christoph Brune, Ian B. Wilkinson, Duncan Jodrell, Joseph Cheriyan

Summary: The study found that in patients receiving the VEGF inhibitor pazopanib, the drug led to hypertension, possibly through increasing peripheral vascular resistance and reducing microvascular density and diameter.

HYPERTENSION (2021)

Article Medicine, General & Internal

Assessment of the causal relevance of ECG parameters for risk of atrial fibrillation: A mendelian randomisation study

Parag Ravindra Gajendragadkar, Adam Von Ende, Maysson Ibrahim, Elsa Valdes-Marquez, Christian Fielder Camm, Federico Murgia, Alexander Stiby, Barbara Casadei, Jemma C. Hopewell

Summary: Using a mendelian randomisation approach, this study found evidence supporting a causal association between lifelong differences in ECG parameters representing longer atrial conduction times within the normal range and a lower risk of AF. These findings suggest the need for more individualised treatment strategies for AF.

PLOS MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Diagnosis of patients with heart failure with preserved ejection fraction in primary care: cohort study

Faye Forsyth, James Brimicombe, Joseph Cheriyan, Duncan Edwards, F. D. Richard Hobbs, Navazh Jalaludeen, Jonathan Mant, Mark Pilling, Rebekah Schiff, Clare J. Taylor, M. Justin Zaman, Christi Deaton

Summary: Identification of HFpEF patients in primary care is challenging, requiring increased awareness and establishment of clear diagnostic pathways. The use of diagnostic algorithms and scores can provide systematic approaches to diagnosis, but may be challenging to apply in older multi-morbid patients.

ESC HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study

Ashutosh Wechalekar, Gunnar Antoni, Wasfi Al Azzam, Mats Bergstrom, Swethajit Biswas, Chao Chen, Joseph Cheriyan, Matthew Cleveland, Louise Cookson, Paul Galette, Robert L. Janiczek, Raymond Y. Kwong, Mary Ann Lukas, Helen Millns, Duncan Richards, Ian Schneider, Scott D. Solomon, Jens Sorensen, James Storey, Douglas Thompson, Guus van Dongen, Danielle J. Vugts, Anders Wall, Gerhard Wikstrom, Rodney H. Falk

Summary: This study reports the results of a Phase 2 trial using the SAP depleter miridesap and dezamizumab in the treatment of cardiac amyloidosis. The results showed that dezamizumab had no significant effect on improving cardiac function or removing cardiac amyloid deposits. Furthermore, treatment-associated rash and vasculitis were observed in the study.

BMC CARDIOVASCULAR DISORDERS (2022)

Article Public, Environmental & Occupational Health

Independent effects of adiposity measures on risk of atrial fibrillation in men and women: a study of 0.5 million individuals

C. Fielder Camm, Ben Lacey, M. Sofia Massa, Adam Von Ende, Parag Gajendragadkar, Alexander Stiby, Elsa Valdes-Marquez, Sarah Lewington, Rohan Wijesurendra, Sarah Parish, Barbara Casadei, Jemma C. Hopewell

Summary: The study found that weight, measures of adiposity, waist circumference, and lean mass (LM) are associated with the risk of atrial fibrillation (AF). LM was the strongest predictor, but its effect was weaker in men compared to women.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2022)

Review Pharmacology & Pharmacy

Niclosamide-A promising treatment for COVID-19

Shivani Singh, Anne Weiss, James Goodman, Marie Fisk, Spoorthy Kulkarni, Ing Lu, Joanna Gray, Rona Smith, Morten Sommer, Joseph Cheriyan

Summary: This article reviews the pharmacology and scientific rationale for repurposing niclosamide, an anti-helminth drug, for the treatment of COVID-19. It highlights the drug's potent antiviral activity and its pleiotropic effects in preclinical and early clinical studies. The advantages and rationale for nebulized and intranasal formulations of niclosamide are also discussed, along with an overview of ongoing clinical trials.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Diagnosis of patients with heart failure with preserved ejection fraction in primary care: cohort study

Faye Forsyth, James Brimicombe, Joseph Cheriyan, Duncan Edwards, F. D. Richard Hobbs, Navazh Jalaludeen, Jonathan Mant, Mark Pilling, Rebekah Schiff, Clare J. Taylor, M. Justin Zaman, Christi Deaton

Summary: The study found that identifying HFpEF patients in primary care is challenging and greater awareness of the condition and specialist support are needed. The use of diagnostic algorithms and scores can provide systematic approaches to diagnosis, but may be challenging to apply in older, multi-morbid patients, requiring pragmatic decisions.

ESC HEART FAILURE (2022)

No Data Available